Gish Biomedical competitors

Zippia score 3.7

Competitor Summary. See how Gish Biomedical compares to its main competitors:

Nevro has the most employees (804).

Work at Gish Biomedical?

Share your experience

Gish Biomedical vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
Gish Biomedical	1976	3.7	Rancho Santa Margarita, CA	1	$7.5M	100
Cardiovascular Systems	1989	4.7	Saint Paul, MN	3	$236.2M	780
Dextera Surgical	1997	3.8	Redwood City, CA	1	$3.4M	50
Escalon Medical	1987	3.9	Wayne, PA	1	$9.4M	20
Nevro	2006	4.7	Redwood City, CA	1	$408.5M	804
Cardima	-	4.0	Fremont, CA	1	-	50
HYPERTENSION DIAGNOSTICS	1988	3.8	Eagan, MN	1	$3.2M	2
Oscor	1982	4.2	Palm Harbor, FL	2	$28.9M	100
Celerus Diagnostics	2004	3.6	Carpinteria, CA	1	$1.0M	30
Genesis Pharmaceutical	-	3.7	Hazel Park, MI	1	$1.5M	50
Adams Respiratory Therapeutics	1997	4.1	Chester, NJ	1	$440.0M	750
TP Orthodontics	1942	3.9	La Porte, IN	1	$26.0M	156
Insightra Medical	2001	4.2	Irvine, CA	2	$3.1M	31
DUSA Pharmaceuticals	1991	4.4	Wilmington, MA	1	$45.3M	50

Rate how well Gish Biomedical differentiates itself from its competitors.

Gish Biomedical salaries vs competitors

Compare Gish Biomedical salaries vs competitors

Company	Average salary	Hourly salary	Salary score
Gish Biomedical	$64,838	$31.17	-

Compare Gish Biomedical job title salaries vs competitors

Company	Highest salary	Hourly salary
Gish Biomedical	$71,944	$34.59
Oscor	$76,162	$36.62
DUSA Pharmaceuticals	$75,706	$36.40
Adams Respiratory Therapeutics	$75,081	$36.10
Cardiovascular Systems	$74,344	$35.74
Genesis Pharmaceutical	$72,824	$35.01
Cardima	$72,309	$34.76
Nevro	$72,281	$34.75
Insightra Medical	$71,957	$34.59
TP Orthodontics	$71,143	$34.20
Dextera Surgical	$70,571	$33.93
Celerus Diagnostics	$70,555	$33.92
Escalon Medical	$70,488	$33.89
HYPERTENSION DIAGNOSTICS	$70,430	$33.86

Do you work at Gish Biomedical?

Is Gish Biomedical able to compete effectively with similar companies?

Gish Biomedical jobs

Gish Biomedical demographics vs competitors

Compare gender at Gish Biomedical vs competitors

Job title	Male	Female
Cardiovascular Systems	43%	57%
Gish Biomedical	73%	27%
Nevro	81%	19%

Male

Female

100%

75%

50%

25%

Nevro

Gish Biomedical

Cardiovascular Systems

25%

50%

75%

100%

Compare race at Gish Biomedical vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Gish Biomedical	52%	17%	8%	14%	8%	6.6
Cardiovascular Systems	61%	14%	9%	13%	3%	9.7
Nevro	49%	18%	7%	19%	7%	9.0

Gish Biomedical and similar companies CEOs

CEOBio

Scott R. Ward

Cardiovascular Systems

Mr. Ward has been a member of our Board of Directors since 2013 and has served as Chairman since November 2014. Mr. Ward served as our Interim President and Chief Executive Officer commencing in November 2015. In August 2016, Mr. Ward was appointed President and Chief Executive Officer. Since 2013, Mr. Ward has been one of the Managing Directors at SightLine Partners. Following his appointment as our President and Chief Executive Officer, Mr. Ward continues to be a Managing Director of Sightline Opportunity Management Fund II, LLC, and may provide limited advisory and consulting services to Sightline Partners in this capacity.

Julian N Nikolchev

Dextera Surgical

D. Keith Grossman

Nevro

D. Keith Grossman was named CEO and President of Nevro in March of 2019. Mr. Grossman has over 30 years of experience in the medical device field. He served most recently, and for the second time, as the President, Chief Executive Officer and director of Thoratec Corporation, leading up to its 2015 sale to St. Jude Medical. Prior to Thoratec, he served as President, Chief Executive Officer and director of Conceptus, a women’s health medical device company, leading up to its sale to Bayer Healthcare. Prior to Conceptus, Mr. Grossman served as managing director of TPG (Texas Pacific Group), a private equity firm, as a member of its healthcare investment team. Prior to TPG, Mr. Grossman served as Thoratec’s President, Chief Executive Officer and director for the first ten years of its growth as a commercial company. Mr. Grossman currently serves as Vice Chairman of Alcon, Inc., Chairman of Outset Medical, Inc. (privately held), and Board member of ViewRay, Inc. and previously served as a member of the Board of directors of Intuitive Surgical, Inc., Kyphon, Inc., and a number of privately held medical device companies. Mr. Grossman received a B.S. in life sciences from The Ohio State University and an M.B.A. from Pepperdine University.

Liangjian Peng

HYPERTENSION DIAGNOSTICS

David R. Gross

Celerus Diagnostics

David R. Gross is a Chief Executive Officer at Celerus Diagnostics.

Richard J Depiano Jr

Escalon Medical

Rich DePiano is a CEO at ESCALON MEDICAL CORP.

Thomas Osypka

Oscor

Thomas Osypka is a President/CEO at Oscor Inc and Board Member at Micro Interventional Devices.

Andrew Kesling

TP Orthodontics